| Mar 4, 2014
| 9:13 PM
Some of the nation's largest pharmaceutical companies have slashed payments to health professionals for promotional speeches amid heightened public scrutiny of such spending, a new ProPublica analysis shows.
| Mar 2, 2014
| 3:12 AM
ZURICH (Reuters) - Swiss pharma group Novartis will work more closely with rival Roche but rules out a merger, its chairman said in a newspaper interview on Sunday.
Asked whether the two companies wanted to stay independent, Joerg Reinhardt, who took...
| Feb 19, 2014
| 10:24 PM
Feb 20 (Reuters) - The following are the top stories in the
Wall Street Journal. Reuters has not verified these stories and
does not vouch for their accuracy.
* Nelson Peltz's Trian Fund is renewing its campaign to
split up PepsiCo Inc's snacks and...
| Mar 25, 2013
| 6:50 PM
Bob Toomajian worked for 16 years as Kaiser Permanente's drug purchasing manager for Southern California, giving him an insider's knowledge of how medications are priced before reaching consumers.
When it comes to patented name-brand drugs, he told me,...
| Mar 14, 2010
| 4:32 PM
A combination of drugs that researchers hoped would delay progression to diabetes and/or heart disease in people with impaired glucose tolerance provided little benefit, researchers reported Sunday at an Atlanta meeting of the American College of...